134 related articles for article (PubMed ID: 16857299)
21. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
[TBL] [Abstract][Full Text] [Related]
22. Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer.
Machens A; Hoffmann F; Sekulla C; Dralle H
Endocr Relat Cancer; 2009 Dec; 16(4):1291-8. PubMed ID: 19726541
[TBL] [Abstract][Full Text] [Related]
23. Spurious hypercalcitoninemia and heterophilic antibodies in patients with thyroid nodules.
Giovanella L; Suriano S
Head Neck; 2011 Jan; 33(1):95-7. PubMed ID: 20848426
[TBL] [Abstract][Full Text] [Related]
24. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer.
Colombo C; Verga U; Mian C; Ferrero S; Perrino M; Vicentini L; Dazzi D; Opocher G; Pelizzo MR; Beck-Peccoz P; Fugazzola L
J Clin Endocrinol Metab; 2012 Mar; 97(3):905-13. PubMed ID: 22170709
[TBL] [Abstract][Full Text] [Related]
25. Medullary thyroid carcinoma: genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitoninemia.
Chi DD; Moley JF
Surg Oncol Clin N Am; 1998 Oct; 7(4):681-706. PubMed ID: 9735129
[TBL] [Abstract][Full Text] [Related]
26. Basal calcitonin levels and the response to pentagastrin stimulation in patients after kidney transplantation or on chronic hemodialysis as indicators of medullary carcinoma.
Kotzmann H; Schmidt A; Scheuba C; Kaserer K; Watschinger B; Söregi G; Niederle B; Vierhapper H
Thyroid; 1999 Sep; 9(9):943-7. PubMed ID: 10524574
[TBL] [Abstract][Full Text] [Related]
27. The essential use of FNA-calcitonin for detecting medullary thyroid cancer.
Trimboli P; Guidobaldi L; Crescenzi A; Bongiovanni M; Giovanella L
Endocrine; 2014 Sep; 47(1):342-4. PubMed ID: 24610209
[No Abstract] [Full Text] [Related]
28. Refining calcium test for the diagnosis of medullary thyroid cancer: cutoffs, procedures, and safety.
Mian C; Perrino M; Colombo C; Cavedon E; Pennelli G; Ferrero S; De Leo S; Sarais C; Cacciatore C; Manfredi GI; Verga U; Iacobone M; De Pasquale L; Pelizzo MR; Vicentini L; Persani L; Fugazzola L
J Clin Endocrinol Metab; 2014 May; 99(5):1656-64. PubMed ID: 24552221
[TBL] [Abstract][Full Text] [Related]
29. Early diagnosis of medullary thyroid carcinoma: is systematic calcitonin screening appropriate in patients with nodular thyroid disease?
Costante G; Filetti S
Oncologist; 2011; 16(1):49-52. PubMed ID: 21212427
[TBL] [Abstract][Full Text] [Related]
30. Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects.
Karanikas G; Moameni A; Poetzi C; Zettinig G; Kaserer K; Bieglmayer C; Niederle B; Dudczak R; Pirich C
J Clin Endocrinol Metab; 2004 Feb; 89(2):515-9. PubMed ID: 14764755
[TBL] [Abstract][Full Text] [Related]
31. Hypercalcitoninemia and thyroid nodules: when cytology (still) matters.
Giovanella L; Giugliano G; Maffini FA; Chiesa F; Bongiovanni M
Diagn Cytopathol; 2014 Nov; 42(11):970-3. PubMed ID: 24550235
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of hypercalcitoninemia in patients on maintenance dialysis referred to kidney transplantation.
Akan B; Böhmig G; Sunder-Plassmann G; Borchhardt KA
Clin Nephrol; 2009 May; 71(5):538-42. PubMed ID: 19473614
[TBL] [Abstract][Full Text] [Related]
33. Biochemical results of reoperations for medullary thyroid carcinoma.
Fernandez Vila JM; Peix JL; Mandry AC; Mezzadri NA; Lifante JC
Laryngoscope; 2007 May; 117(5):886-9. PubMed ID: 17473689
[TBL] [Abstract][Full Text] [Related]
34. A case of spurious hypercalcitoninemia: a cautionary tale on the use of plasma calcitonin assays in the screening of patients with thyroid nodules for neoplasia.
Uwaifo GI; Remaley AT; Stene M; Reynolds JC; Yen PM; Snider RH; Becker KL; Sarlis NJ
J Endocrinol Invest; 2001 May; 24(5):361-9. PubMed ID: 11407657
[TBL] [Abstract][Full Text] [Related]
35. Routine serum calcitonin measurement in the evaluation of thyroid nodules.
Elisei R
Best Pract Res Clin Endocrinol Metab; 2008 Dec; 22(6):941-53. PubMed ID: 19041824
[TBL] [Abstract][Full Text] [Related]
36. Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease.
Rink T; Truong PN; Schroth HJ; Diener J; Zimny M; Grünwald F
Thyroid; 2009 Apr; 19(4):327-32. PubMed ID: 19355822
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic Utility of Procalcitonin for Sporadic Medullary Thyroid Carcinoma in Patients with Nodular Disease and Mild or Moderate Hypercalcitoninemia.
Rosario PW; Mourão GF
Horm Metab Res; 2022 Apr; 54(4):220-223. PubMed ID: 35413742
[TBL] [Abstract][Full Text] [Related]
38. Mild hypercalcitoninaemia and sporadic thyroid disease.
Cherenko M; Slotema E; Sebag F; De Micco C; Henry JF
Br J Surg; 2010 May; 97(5):684-90. PubMed ID: 20235084
[TBL] [Abstract][Full Text] [Related]
39. Hypercalcitoninemia, pheochromocytoma, and C-cell hyperplasia. A new variant of Sipple's syndrome.
Ram MD; Rao KN; Brown L
JAMA; 1978 May; 239(20):2155-60. PubMed ID: 642160
[No Abstract] [Full Text] [Related]
40. The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders: results from 2733 consecutive patients.
Chambon G; Alovisetti C; Idoux-Louche C; Reynaud C; Rodier M; Guedj AM; Chapuis H; Lallemant JG; Lallemant B
J Clin Endocrinol Metab; 2011 Jan; 96(1):75-81. PubMed ID: 20881258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
